Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Surya Pertiwi Tbk. (SPTO)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Surya Pertiwi Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Surya Pertiwi Tbk. diperdagangkan di Rp600 (kapitalisasi pasar 1,66 T, volume 24 jam 1,82 jt). Perbedaan utamanya: Surya Pertiwi Tbk. jauh lebih besar — sekitar 15,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SPTO | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,66 T |
Volume | — | 1,82 jt |
Lot | — | 18,22 rb |
Perputaran | — | 1,1 M |
Harga Rata-rata | — | 603,1 |
Nilai Transaksi | — | 1,1 M |
Harga Ekuilibrium Indikatif | — | 600 |
Volume Ekuilibrium Indikatif | — | 1 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Surya Pertiwi Tbk.
PT Surya Pertiwi Tbk (the Company) formerly PT Surya Nusantara was established in the Republic of Indonesia on July 5, 1978 and was published in State Gazette No. 172, Supplement No. 31 dated April 17, 1979 based on Notarial Deed No. 1 of Hendra Karyadi, S.H.
Selengkapnya di halaman SPTO →
